Mechanisms coupling lipid droplets to MASLD pathophysiology.

Area of Science:

• Hepatology
• Cell Biology
• Biochemistry

Background:

• Hepatic steatosis, or fatty liver, is the accumulation of lipids in liver cells.
• Metabolic dysfunction-associated steatotic liver disease (MASLD) includes simple steatosis and steatohepatitis, marked by inflammation and injury.
• Lipid droplets (LDs), once thought inert, are now recognized for active roles in liver disease.

Purpose of the Study:

• To review lipid droplet biology.
• To discuss mechanisms by which LDs contribute to advanced liver disease, including MASLD.

Main Methods:

• Literature review of lipid droplet functions in liver disease.
• Analysis of protein regulation of LDs.
• Discussion of LD roles in cell signaling and lipid metabolism.

Main Results:

• LDs are dynamic organelles with critical nonpathological and pathological functions.
• Hundreds of proteins on LD surfaces regulate lipid metabolism, trafficking, and signaling.
• LDs actively participate in the development of liver diseases like MASLD.

Conclusions:

• Lipid droplets are key players in the pathogenesis of metabolic dysfunction-associated steatotic liver disease.
• Understanding LD regulation by surface proteins is crucial for targeting liver disease progression.
• Further research into LD biology can illuminate therapeutic strategies for MASLD and steatohepatitis.